Clinical trial
A Study to Evaluate the Discontinuation Effect of Clopidogrel After Drug Eluting…
NCT00493779 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00493779 |
|---|---|
| Title | A Study to Evaluate the Discontinuation Effect of Clopidogrel After Drug Eluting Stent Implantation in Non-diabetic Patients |
| Official title | An Exploratory, Multi-Center, Open-Label, Single-Arm Study to Evaluate the Discontinuation Effect of Clopidogrel After Drug Eluting Stent (DECADES) on Inflammatory and Platelet Activation Markers in Subjects Who Are Receiving Low Dose Acetylsalicylic Acid (ASA) |
| Acronym | DECADES |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Antiplatelet Aggregation |
| Intervention type | Procedure |
| Interventions | Blood Collection |
| Enrollment | 103 |
| Start date | Oct 1, 2007 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Jun 28, 2007 |
| Last update posted | Aug 10, 2010 |
| Countries | France, Germany, Netherlands, United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: